LUCID DIAGNOSTICS INC.

Analyst Reco. Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
0.93 ^USD	+2.76%		-2.11%	-34.04%

May. 13	Transcript : Lucid Diagnostics Inc., Q1 2024 Earnings Call, May 13, 2024
May. 13	Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	Mar. 27	MT
Needham Adjusts Price Target on Lucid Diagnostics to $2.80 From $2.60, Maintains Buy Rating	23-05-17	MT
BTIG Adjusts Lucid Diagnostics' Price Target to $3.50 From $5, Keeps Buy Rating	22-11-18	MT
Needham Adjusts Price Target on Lucid Diagnostics to $3.10 From $4.25, Maintains Buy Rating	22-11-15	MT
Needham Cuts Price Target on Lucid Diagnostics to $4.25 From $5, 2023 Revenue Estimate to $15 Million From $20.8 Million; Buy Rating Kept	22-08-16	MT
Needham Adjusts Lucid Diagnostics' Price Target to $5 From $7 on 'Peer Multiple Compression,' Reiterates Buy Rating	22-05-12	MT
Canaccord Genuity Adjusts Lucid Diagnostics' Price Target to $12 From $18, Reiterates Buy Rating	22-03-29	MT
Needham Adjusts Lucid Diagnostics' Price Target to $7 From $13, Citing Peer Multiple Compression, Lowered Revenue Expectation; Buy Rating Kept	22-03-29	MT
Ascendiant Capital Starts Lucid Diagnostics at Buy With $16 Price Target	21-12-27	MT
Needham Lowers Lucid Diagnostics' Price Target to $13 From $17, Citing 'Peer Multiple Contraction;' Buy Rating Kept	21-12-15	MT
Canaccord Genuity Initiates Lucid Diagnostics at Buy Rating With $18 Price Target	21-11-08	MT
BTIG Starts Lucid Diagnostics at Buy with $14 Price Target	21-11-08	MT
Cantor Fitzgerald Starts Lucid Diagnostics at Overweight With $21 Price Target	21-11-08	MT
Needham Starts Lucid Diagnostics at Buy With $17 Price Target	21-11-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW